← All diseases
Liver, kidneys and digestion
Liver cirrhosis
Would you like to receive a message when there is new research about Liver cirrhosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cirrhosis is available. View what Premium costs.
Publications and studies (3107)
- Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice. (2026/12/31) ♡
- Lonicerin from Dachaihu decoction ameliorates liver steatosis and fibrosis in MASH by inhibiting LY6D. (2026/12/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment strategies and prospects for hepatic fibrosis: Application of traditional Chinese medicine polysaccharides in modulating of the TGF-β1/Smad pathway. (2026/11/15) ♡
- Yi-Qi-Jian-Pi formula alleviates hepatic fibrosis in acute-on-chronic liver failure by regulating ferritinophagy-mediated hepatic stellate cell senescence. (2026/10/28) ♡
- Intracellular imaging and therapeutic application of liver fibrosis via a microRNA-on self-stacking amplification circuit. (2026/10/08) ♡
- Explainable machine learning models predict liver fibrosis risk and outcome in the general population: Development and multi-cohort external validation. (2026/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review). (2026/10/01) ♡
- Fuzheng Huayu formula attenuates ductular reaction and liver fibrosis potentially through suppressing Gli1 pathway. (2026/09/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Role of Magnetic Resonance Elastography in the Assessment of Liver Fibrosis: A Descriptive Study. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutrition in cirrhosis: bridging guidelines and practice in hepatic disease. (2026/09/01) ♡
- Validation of a Point-Of-Care Ultrasound for Hepatitis Among Front-Line Healthcare Workers Managing Chronic Hepatitis B Virus Infection in Zambia. (2026/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis - Authors' reply. (2026/09/01) ♡
- The Impact of Chronic Hepatitis D Virus Infection on Health-Related Quality of Life and Fatigue: A Real-World International Study. (2026/09/01) ♡
- Characterising Hepatitis D Virus in the UK From 2011 to 2021. (2026/09/01) ♡
- Huaganjian decoction attenuates liver fibrosis via purine metabolic-inflammatory synergistic crosstalk: network pharmacology combined with multi-omics analyses. (2026/09/01) ♡
- Qi Wei Zhi Gan formulation alleviates progressive fibrosis in metabolic dysfunction-associated steatohepatitis through suppressing Peroxidasin-collagen IV crosslinking. (2026/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Pien-Tze-Huang inhibits colorectal cancer liver metastasis in mice by modulating immunosuppressive and fibrotic microenvironments. (2026/09/01) ♡
- Jianpi Huayu decoction alleviates hepatic fibrosis involving coordinated modulation of PPARα-mediated lipid metabolic reprogramming and the ROCK pathway. (2026/09/01) ♡
- Noncoding RNA Transcripts Based Molecular Phenotyping of MASLD and MASH Patients. (2026/09/01) ♡
- [Analysis of influencing factors associated with cirrhosis in patients with indeterminate-phase chronic hepatitis B]. (2026/08/11) ♡
- Esculin attenuates cholestatic liver injury and fibrosis in bile duct-ligated rats by modulating oxidative stress, inflammatory responses, and fibrogenic mediators. (2026/08/10) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. miR-26b-modified human umbilical cord mesenchymal stem cells exhibit enhanced anti-fibrotic efficacy in a mouse model of hepatic fibrosis. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Alcohol-Related Liver Disease After Metabolic Bariatric Surgery: Reassessing the Hidden Risk-A Meta-Analysis. (2026/08/10) ♡
- Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study. (2026/08/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective. (2026/08/09) ♡
- Hepatocyte VDR protects against cirrhosis-associated bone loss via repression of the FN1/Integrin αv signaling. (2026/08/08) ♡
- Sleep Irregularity is Associated with Reduced Wellbeing in Patients with Cirrhosis. (2026/08/08) ♡
- HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy. (2026/08/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. What a Placebo Arm Measures: Biopsy Misclassification and Embedded Lifestyle Care in Pooled Cirrhosis Incidence for Fibrotic MASH. (2026/08/08) ♡
- Acute-on-chronic liver failure following pneumonia in an elderly woman with metabolic dysfunction-associated steatotic liver cirrhosis. (2026/08/07) ♡
- Effects of laparoscopic splenectomy and azygoportal disconnection on liver reserve function for cirrhosis patients: a 1-year prospective study. (2026/08/07) ♡
- Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds. (2026/08/07) ♡
- Stigmatizing language in alcohol-associated cirrhosis open notes: Persistent but declining. (2026/08/07) ♡
- The creatinine-to-albumin ratio as a prognostic indicator in critically ill patients with cirrhosis: A cohort study. (2026/08/07) ♡
- miR149-5p: A hepatocyte EXOmotif sequence containing microRNA that attenuates liver fibrosis by specifically targeting PDGFRB in HSCs. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The dynamic spectrum of steatotic liver disease: the global perspective. (2026/08/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. "From Cholestasis to Interface Hepatitis: A Rare Case of Primary Sclerosing Cholangitis-Autoimmune Hepatitis Overlap in a 20-Year-Old Male". (2026/08/07) ♡
- Liver, Portal, and Systemic Thyroid Hormone Concentrations in End-Stage MASH Reveal Distinct Roles for T3/rT3 Ratio and T4. (2026/08/06) ♡
- Sorrow, Unpermitted: A Narrative Review of Grief in Chronic Liver Disease. (2026/08/06) ♡
- VITRO score dynamics after liver transplantation predict portal-hypertensive events and post-transplant mortality. (2026/08/06) ♡
- Machine learning-derived clinical phenotypes of ascites in cirrhosis: A multi-center latent class analysis with external validation. (2026/08/06) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter: The Promotion of Lemborexant in Patients With Liver Cirrhosis and Insomnia-Limitations of Population Generalisation and Liver Safety. (2026/08/06) ♡
- Sodium Glucose Co-Transporter 2 Inhibitors Use in Diabetic Patients with Cirrhosis Improves Liver-related Outcomes and Survival. (2026/08/06) ♡
- Impact of Obeticholic Acid Therapy on Insulin Resistance and Metabolic Parameters in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). (2026/08/06) ♡
- With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1. (2026/08/06) ♡
- Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Relevance of Bile Acid and Bile Acid-Related Therapy in Liver Cirrhosis: A Review. (2026/08/05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparison of underdilated versus standard transjugular intrahepatic portosystemic shunt in preventing rebleeding from oesophagogastric varices in patients with cirrhosis in Chinese tertiary hospitals: protocol for a multicentre randomised controlled trial (UVR-TIPS trial). (2026/08/05) ♡
- Patient awareness of viral hepatitis infection in Al-Madinah, Saudi Arabia: a cross-sectional study. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Modulation for Liver Regeneration in Hepatocellular Carcinoma: From Biological Mechanisms to Precision Regenerative Medicine. (2026/08/05) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.